Tumor growth was significantly attenuated in syngeneic tumor-bearing mice treated with mouse FOXP3 ASO, with a partial reduction in FOXP3 mRNA (20%–60% compared with baseline). This evidence concerns the gene FOXP3 and neoplasm.